Skip to main content
. 2016 Jun 8;6:27442. doi: 10.1038/srep27442

Table 1. Baseline characteristics of participants who did not develop incident CVD and those who developed incident CVD.

  No CVD events (N = 3370) CVD events (N = 126) p-value
  Mean (SD)/N (%) Mean (SD)/N (%)  
Age, years 52.93 (8.89) 61.45 (11.72) <0.001
Ethnicity (Chinese/Malay/Indian) 1625 (48.22)/1249 (37.06)/496 (14.72) 37 (29.37)/61 (48.41)/28 (22.22) <0.001
Gender, male 1603 (47.57) 97 (76.98) <0.001
Body mass index, kg/m2 24.74 (4.54) 25.21 (4.49) 0.257
Systolic blood pressure, mmHg 135.85 (20.96) 153.83 (25.73) <0.001
Diastolic blood pressure, mmHg 79.17 (10.69) 85.60 (13.07) <0.001
Total cholesterol, mmol/L 5.37 (0.96) 5.57 (1.15) 0.023
HDL cholesterol, mmol/L 1.39 (0.34) 1.22 (0.27) <0.001
LDL cholesterol, mmol/L 3.41 (0.92) 3.50 (0.72) 0.524
Estimate glomerular filtration rate, mL/min/1.73 m2 83.38 (16.87) 72.41 (17.37) <0.001
High sensitivity C-reactive protein, mg/L 3.00 (6.52) 3.50 (7.51) 0.416
Microalbuminuria, yes 460 (13.65) 45 (35.71) <0.001
Diabetes, yes 1099 (32.61) 57 (45.24) 0.003
Hypertension, yes 1576 (46.77) 92 (73.02) <0.001
Current smoking, yes 577 (14.15) 42 (33.33) <0.001
Retinal arteriolar caliber, μm 141.66 (14.54) 137.59 (15.78) 0.002
Retinal venular caliber, μm 219.80 (20.67) 224.16 (21.0) 0.002
Any retinopathy, yes 285 (8.37) 25 (19.84) <0.001

*p-value for differences between subjects who did not develop incident CVD and those who developed incident CVD, by t-test or chi-square test as appropriate.

HHS Vulnerability Disclosure